SCHEMBL10296266

SCHEMBL10296266

CC[S+]([O-])Nc1ccc(CCCCC2CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 18/20 0.49
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1575684 0.83 GPR119 (0.53) GPR119
SCHEMBL1575459 0.83 PTPN2 (0.54) GPR119
SCHEMBL1575330 0.83 GPR119 (0.53) GPR119
SCHEMBL1575376 0.82 GPR119 (0.53) GPR119
SCHEMBL1575460 0.82 PTPN2 (0.65) GPR119
SCHEMBL1576176 0.81 PTPN2 (0.50) GPR119
SCHEMBL1575070 0.81 GPR119 (0.57) GPR119
SCHEMBL1575161 0.81 GPR119 (0.53) GPR119
SCHEMBL1575547 0.80 PTPN2 (0.51) GPR119ALDH1A1
SCHEMBL1575795 0.80 GPR119 (0.54) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120172358-A1 GPCR Agonists PROSIDION LIMITED (GB) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172358-A1 GPCR Agonists GPR119, GCGR, GPR27 GPR119 1/4885ALDH1A1 1059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.